Bristol Myers Squibb buys San Diego cancer therapy company for $4.8B

  • 📰 sdut
  • ⏱ Reading Time:
  • 21 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 12%
  • Publisher: 95%

United States News News

United States United States Latest News,United States United States Headlines

It's unclear what the Bristol Myers Squibb deal with San Diego's Mirati Therapeutics means for the local workforce.

Mirati Therapeutics, a San Diego biotechnology company developing commercial drugs for cancer treatment, was just purchased by a pharmaceutical giant for more than $4.8 billion. Bristol Myers Squibb, one of the world’s largest pharmaceutical companies, announced Sunday evening that it will buy Mirati for $58 per share in a deal funded by cash and debt. There is potential for an additional $1 billion in milestone payments. The deal is expected to close in the first half of next year.

Mirati Therapeutics has been in San Diego developing treatments targeted at the genetic and immunological causes of cancer for 28 years. The biotech employed 593 people at the end of last year. In addition to Krazati, Bristol Myers Squibb gains access to Mirati’s pipeline of potential treatments for lung, bile duct and skin cancer tumors, as well as tumor mutations in pancreatic, lung and colorectal cancers.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 5. in US

United States United States Latest News, United States United States Headlines